Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Marine-Derived Pharmaceuticals in Clinical Trials in 2022
HTML
PDF
Details
Locations
Year:
2023
Type:
article
Source:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.122.527010
Authors:
Alejandro MS. Mayer,
Marsha Pierce,
Maria Reji,
Alex C. Wu,
Karolina K. Jekielek,
Henry Q. Le,
Katelyn Howe,
Maryam Butt,
Sujin Seo,
David J. Newman,
Keith B. Glaser
show all 11
Institutions:
Midwestern University,
AbbVie (United States)
Language:
English
Topic:
Marine Sponges and Natural Products
Subfield:
Biotechnology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
marine-derived drugs,
marine natural products,
antibody-drug conjugates,
microtubule inhibitors,
EphA2,
nectin-4,
EGFR,
HER2,
mesothelin,
CD38,
amyloidosis,
cancer therapy,
drug development pipeline,
clinical trials,
FDA drug approval,
marine metabolites,
drug repurposing
show all 17
SDG:
Good health and well-being
Open Access status:
bronze
Funder:
Midwestern University
OpenAlex ID:
W4377029528
FWCI:
0.694
Cites:
Cited by:
9
Related to:
10